BlackRock Fund Advisors’s Collegium Pharmaceutical COLL Stock Holding History

BlackRock Fund Advisors’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$14.5M	Buy	931,081 +237,026	+34%	+$3.94M	﹤0.01%	2362
2016 Q3	$13.4M	Buy	694,055 +43,581	+7%	+$518K	﹤0.01%	2298
2016 Q2	$7.71M	Buy	650,474 +147,461	+29%	+$2.44M	﹤0.01%	2558
2016 Q1	$9.13M	Buy	503,013 +84,819	+20%	+$1.54M	﹤0.01%	2411
2015 Q4	$11.5M	Buy	418,194 +243,639	+140%	+$5.13M	﹤0.01%	2363
2015 Q3	$3.86M	Sell	174,555 -2,421	-1%	-$43.8K	﹤0.01%	2928
2015 Q2	$3.16M	Buy	+176,976	New	+$3.06M	﹤0.01%	3091

Other funds holding COLL

SAM

Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock Fund Advisors's COLL Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Collegium Pharmaceutical (COLL) stake by 34% in Q4 2016, buying an estimated $3.94M and bringing the position to 931,081 shares worth $14.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2362.

BlackRock Fund Advisors first reported a position in COLL in Q2 2015 and has held it in 7 quarters since. 88 funds tracked by Wall St. Rank hold COLL as of Q4 2016.

BlackRock Fund Advisors held 931,081 shares of Collegium Pharmaceutical worth $14.5M as of Q4 2016.
BlackRock Fund Advisors bought 237,026 Collegium Pharmaceutical shares in Q4 2016, an estimated $3.94M.
Collegium Pharmaceutical made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2362 holding.
BlackRock Fund Advisors first reported a position in Collegium Pharmaceutical in Q2 2015 and has held it in 7 quarters since.
88 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.